EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

FAM193A is a positive regulator of p53 activity

Maria M Szwarc, Anna L Guarnieri, Molishree Joshi, Huy N Duc, Madison C Laird, Ahwan Pandey, Santosh Khanal, Emily Dohm, Aimee K Bui, Kelly D Sullivan, Matthew D Galbraith, Zdenek Andrysik und 1 weitere

Cell Reports · 2023

DOI: 10.1016/j.celrep.2023.112230 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2023. Verfasst von Maria M Szwarc und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA. Hauptthemen laut MEDLINE: Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIDDK NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsNeoplasmsHumansApoptosisCell Cycle ProteinsCell Line, TumorProto-Oncogene ProteinsProto-Oncogene Proteins c-mdm2Tumor Suppressor Protein p53AutoantigensProteins

Stichwörter der Autor:innen

CP: CancerCP: Molecular biologyCRISPRMDM2MDM4MDMXNutlinapoptosiscell-cycle arrestp53

Substanzen

Antineoplastic AgentsCell Cycle ProteinsProto-Oncogene ProteinsProto-Oncogene Proteins c-mdm2Tumor Suppressor Protein p53MDM4 protein, humanFAM193A protein, humanAutoantigensProteins

Autor:innen und Institutionen

  • Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
  • Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA; Functional Genomics Facility, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
  • Functional Genomics Facility, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
  • Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.
  • Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA; Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA; Departme…
  • Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA; Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.

Förderung

  • NCI NIH HHS
  • NIDDK NIH HHS
  • NINDS NIH HHS
  • Cancer Center, University of Colorado
  • National Institutes of Health
  • Anna and John J. Sie Foundation
  • National Cancer Institute
  • Gilead Sciences

Zitieren

APA

Szwarc, M. M., Guarnieri, A. L., Joshi, M., Duc, H. N., Laird, M. C., Pandey, A., Khanal, S., Dohm, E., Bui, A. K., Sullivan, K. D., Galbraith, M. D., Andrysik, Z., & Espinosa, J. M. (2023). FAM193A is a positive regulator of p53 activity. Cell Reports. https://doi.org/10.1016/j.celrep.2023.112230

Vancouver

Szwarc MM, Guarnieri AL, Joshi M, Duc HN, Laird MC, Pandey A, et al. FAM193A is a positive regulator of p53 activity. Cell Reports. 2023. doi:10.1016/j.celrep.2023.112230

BibTeX
@article{Szwarc2023,
  author = {Szwarc, Maria M and Guarnieri, Anna L and Joshi, Molishree and Duc, Huy N and Laird, Madison C and Pandey, Ahwan and Khanal, Santosh and Dohm, Emily and Bui, Aimee K and Sullivan, Kelly D and Galbraith, Matthew D and Andrysik, Zdenek and Espinosa, Joaquin M},
  title = {FAM193A is a positive regulator of p53 activity},
  journal = {Cell Reports},
  year = {2023},
  doi = {10.1016/j.celrep.2023.112230}
}
Kostenlos starten →